Skip to main content
Top
Published in:

Open Access 13-03-2024 | Image

Paederus dermatitis

Authors: Laura C. Kalkman, Omrimaxwell M. Sesay, Martin P. Grobusch

Published in: Infection | Issue 4/2024

Login to get access

Excerpt

A 31-year-old woman of European origin living in rural Sierra Leone developed a faint erythematous lesion on the right forearm at the beginning of the rainy season. Simultaneously, two similar lesions appeared on the chest along the clothing line and on the right eyelid, causing eyelid swelling without any symptoms of conjunctivitis (Fig. 1A–C). Over the course of four days, the lesions on the chest and eyelid subsided, while the lesion on the forearm progressed to a painful erythematous dermatitis (Fig. 1D, E), resembling a lesion caused by exposure to a toxic substance. The skin lesions presented as linear erythematous plaques, with vesicles and bullae appearing at the periphery of the lesion. No systemic symptoms occurred. Pain and inflammation subsided after applying a class III topical corticosteroid.
Fig. 1
Dermatitis linearis. A Secondary erythematous lesions Day 1. B Faint erythematous lesion Day 1. C Erythema and swelling of eyelid. Day 1. Dermatitis on Day 4. E Dermatitis on Day 5. F Paederus beetle collected on site in Masanga, Sierra Leone
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Paederus dermatitis
Authors
Laura C. Kalkman
Omrimaxwell M. Sesay
Martin P. Grobusch
Publication date
13-03-2024
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2024
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-024-02231-y

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more